Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-05

Clinical Trial Update: Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study investigating isonicotinic acid hydrazide pretreatment with misoprostol for inducing abortion in first-trimester misse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isonicotinic acid hydrazide (isonicotinic acid hydrazide)
  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Aswan University Hospital | Conditions: Abortion, Missed | Phase 4 | Status: UNKNOWN